+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Eluting Stent Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Drug Eluting Stent Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Drug Eluting Stent Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 5337072
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Eluting Stent Market grew from USD 8.05 billion in 2024 to USD 8.93 billion in 2025. It is expected to continue growing at a CAGR of 10.87%, reaching USD 14.96 billion by 2030.

Drug eluting stents (DES) have revolutionized cardiovascular intervention by combining mechanical scaffolding with targeted drug delivery to prevent restenosis. Over the past two decades, ongoing research and clinical advances have propelled the technology beyond its initial promise, creating new material formulations, coating strategies, and delivery mechanisms. This introduction sets the stage for an in-depth exploration of the transformative shifts, regulatory and tariff impacts, segmentation depth, regional variances, competitive dynamics, and strategic recommendations guiding decision-makers in a rapidly evolving market.

Transformative Shifts Redefining the Drug Eluting Stent Landscape

Technological breakthroughs in biodegradable polymer matrices have accelerated the transition from durable polymer coatings toward bioabsorbable alternatives, reducing late-stage inflammation and improving long-term vessel healing. Concurrently, refined drug formulations-ranging from sirolimus to everolimus and zotarolimus-have enhanced antiproliferative efficacy while minimizing cytotoxicity. Manufacturers now integrate micro-patterned strut designs with cobalt chromium and platinum chromium alloys to balance radial strength and flexibility, addressing complex lesion morphologies.

Regulatory pathways have adapted to these innovations: expedited review processes and real-world evidence requirements encourage post-market surveillance trials, ensuring patient safety without stalling market entry. Digital health platforms and computational modeling support personalized stent selection and procedural planning, aligning with value-based care initiatives. Meanwhile, partnerships between device makers and academic institutions drive forward novel drug combinations and advanced imaging modalities. As patient populations diversify across age, comorbidity profiles, and diabetic status, the landscape reshapes itself around precision medicine principles. These transformative shifts underscore a future in which collaboration, material science, and data-driven insights redefine interventional cardiology.

Cumulative Impact of United States Tariffs on the Drug Eluting Stent Market

The introduction of United States tariffs on key raw materials and finished medical devices in 2025 has reverberated across supply chains, affecting procurement costs for both domestic producers and international exporters. Manufacturers relying on stainless steel, cobalt chromium, or platinum chromium experienced margin compression as import duties climbed. In response, strategic sourcing initiatives accelerated: some firms diversified suppliers across Asia-Pacific hubs while others negotiated volume-based rebates to offset elevated landed costs.

Hospitals and ambulatory surgical centers faced increased acquisition prices, prompting group purchasing organizations to renegotiate contracts and explore alternate reimbursement models. To mitigate patient access barriers, cardiology clinics shifted toward devices with equivalent clinical outcomes but lower tariff exposure, such as polymer-based stents manufactured in tariff-exempt zones. Industry alliances emerged to lobby for harmonized trade classifications and exemptions for life-saving technologies.

Longer term, businesses optimized inventory buffers, implemented just-in-time logistics, and invested in nearshore production facilities to reduce reliance on subject-tariff imports. These cumulative strategies illustrate how adaptive supply-chain restructuring helps maintain device affordability and preserves critical patient care pathways despite shifting trade policies.

Key Segmentation Insights Revealing Diverse Market Dynamics

The product spectrum spans biodegradable polymer stents, non-polymer-based scaffolds, and durable polymer formulations-each catering to distinct patient risk profiles and physician preferences. Coating technologies divide into non-polymer alternatives, which leverage inorganic reservoirs for drug release, and polymer-coated platforms that either absorb within months or remain durable for controlled drug elution. Material selections include metal stents-engineered from cobalt chromium for optimized radial strength, platinum chromium for enhanced radiopacity, and stainless steel for cost-effective support-and emerging polymer lattice constructs that promise biodegradable scaffolding.

Clinical applications expand beyond coronary interventions to peripheral vascular disease and renal artery stenosis, meeting demand across diabetic and non-diabetic patient cohorts. Delivery systems vary from high-precision balloon-expandable devices to flexible, self-expanding frameworks designed for tortuous anatomies. End users encompass hospitals, split between academic centers conducting cutting-edge trials and private institutions focused on throughput efficiency; ambulatory surgical centers; cardiology clinics; and research and academic institutes driving preclinical and post-market surveillance studies. Drug agents span paclitaxel, sirolimus, everolimus, biolimus, and zotarolimus, each chosen for its pharmacokinetic profile and safety margin. Market maturity divides into first, second, and third generations of DES, reflecting iterative enhancements in polymer science, strut thickness, and elution control. Clinical trial phases range from preclinical evaluations and Phase I safety assessments to Phase II/III efficacy studies and post-market surveillance efforts, ensuring rigorous performance validation at every stage.

Key Regional Insights Shaping Global Market Opportunities

In the Americas, established reimbursement frameworks and high procedural volumes support rapid adoption of third-generation systems incorporating bioabsorbable polymers and advanced drug chemistries. Leading interventional cardiology centers in North America participate in expansive clinical registries, fueling continuous innovation. Conversely, Latin American markets focus on cost-effective stainless steel scaffolds and partnership models to improve access.

The Europe, Middle East & Africa region presents a mosaic of regulatory environments and economic capabilities. Western Europe emphasizes premium durable polymer platforms backed by robust health insurance schemes and centralized procurement tenders. In contrast, the Middle East invests in digital catheterization labs, integrating telemedicine to extend specialized care across remote areas. African markets gradually adopt basic DES technologies, often through government initiatives that subsidize imports to curb escalating cardiovascular disease burdens.

Asia-Pacific stands out for manufacturing scale, particularly in polymer-coated stent production across Southeast Asia and device design hubs in Japan and South Korea. China prioritizes indigenous R&D on drug coatings and high-strength alloys, while India’s private hospital networks drive usage among diabetic populations. Regional dynamics underscore the importance of tailored commercial strategies, from tiered pricing to strategic alliances, ensuring that innovations reach diverse patient groups.

Key Company Insights Driving Industry Innovation and Growth

Abbott Laboratories and Boston Scientific Corporation maintain leadership through expansive portfolios that include cobalt chromium stents and next-generation polymer coatings supported by extensive clinical evidence. Medtronic PLC leverages its global distribution network and diversified material expertise, while Terumo Corporation capitalizes on strong relationships with end users in Asia and Europe.

Biotronik and Biosensors International Group, Ltd. focus on targeted drug chemistries and low-profile delivery systems, carving niche positions in peripheral vascular interventions. B. Braun and Cook Medical LLC emphasize customizable system integrations, aligning device performance with interventional imaging modalities. MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and Lepu Medical Technology advance cost-effective polymer scaffolds for emerging markets, balancing affordability with clinical outcomes.

Smaller innovators like Alvimedica, Arkray, Inc., HEXACATH, KYOTO MEDICAL PLANNING Co., Ltd., REVA Medical LLC, and Shandong JW Medical Systems LTD. push boundaries in self-expanding architectures, bioresorbable alloys, and novel drug formulations. Collaboration among these firms and research institutes accelerates iterative improvements, creating a competitive landscape defined by strategic partnerships, licensing agreements, and targeted clinical trials.

Actionable Recommendations for Industry Leaders to Stay Ahead

First, prioritize investment in biodegradable and bioabsorbable polymer research to differentiate portfolios and address growing concerns around late thrombosis. Second, develop flexible supply chains by diversifying raw-material sourcing across tariff-exempt jurisdictions and exploring nearshore manufacturing partnerships. Third, cultivate collaborations with academic and clinical research centers to accelerate Phase II and Phase III trials, generating robust real-world evidence for reimbursement negotiations.

Fourth, implement digital health integrations-such as procedural planning software and remote monitoring platforms-to enhance physician decision-making and patient adherence. Fifth, refine coating technologies to optimize drug release kinetics and minimize inflammatory responses, leveraging novel polymers and nano-delivery systems. Sixth, tailor commercial strategies by region: adapt pricing models in emerging markets and amplify premium offerings in high-reimbursement territories. Seventh, engage with health authorities early to shape favorable regulatory frameworks and tariff exemptions for critical medical devices.

Lastly, build cross-functional teams that include supply-chain analysts, clinical scientists, and market access specialists to anticipate policy changes and patient needs. By adopting these measures, industry leaders can sustain growth, mitigate trade-related risks, and reinforce their position in a competitive environment.

Conclusion and Future Outlook for Drug Eluting Stents

The landscape of drug eluting stents continues to evolve through material innovations, advanced drug formulations, and enhanced delivery systems. Regulatory adaptations and tariff shifts challenge manufacturers to optimize supply chains and pricing strategies, while segmentation analysis reveals myriad opportunities across product types, coatings, materials, applications, and clinical phases. Regional insights highlight the necessity of tailored commercialization approaches, and company intelligence showcases both established multinationals and agile disruptors driving R&D progress.

By integrating strategic recommendations-ranging from polymer R&D investment to digital health integration-organizations can navigate trade complexities, meet diverse patient needs, and strengthen clinical value propositions. Collaboration between device makers, academic institutions, and health systems will underpin future breakthroughs, ensuring that next-generation stents deliver both safety and long-term efficacy. As the market matures, leaders who anticipate regulatory trends, foster innovation, and adapt to evolving reimbursement landscapes will define the trajectory of interventional cardiology.

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Stent Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Biodegradable Polymer Stents
  • Non-Polymer-Based Stents
  • Polymer-Based Stents
  • Non-Polymer Coated Stents
  • Polymer Coated Stents
    • Bioabsorbable Polymer Stents
    • Durable Polymer Stents
  • Metal Stents
    • Cobalt Chromium
    • Platinum Chromium
    • Stainless Steel
  • Polymer Stents
  • Cardiology
  • Peripheral Vascular Disease
  • Renal Artery Stenosis
  • Ambulatory Surgical Centers
  • Cardiology Clinics
  • Hospitals
    • Academic Hospitals
    • Private Hospitals
  • Research and Academic Institutes
  • Biolimus
  • Everolimus
  • Paclitaxel
  • Sirolimus
  • Zotarolimus
  • First Generation
  • Second Generation
  • Third Generation
  • Diabetic Patients
  • Non-Diabetic Patients
  • Balloon Expandable
  • Self-Expanding
  • Phase I
  • Phase II
  • Phase III
  • Post-Market Surveillance
  • Preclinical Studies

This research report categorizes the Drug Eluting Stent Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Drug Eluting Stent Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • Alvimedica
  • Arkray, Inc.
  • B. Braun
  • Biosensors International Group, Ltd.
  • Biotronik
  • Boston Scientific Corporation
  • Cook Medical LLC
  • HEXACATH
  • KYOTO MEDICAL PLANNING Co., Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • REVA Medical LLC
  • Shandong JW Medical Systems LTD.
  • Terumo Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Eluting Stent Market, by Product Type
8.1. Introduction
8.2. Biodegradable Polymer Stents
8.3. Non-Polymer-Based Stents
8.4. Polymer-Based Stents
9. Drug Eluting Stent Market, by Coating Technology
9.1. Introduction
9.2. Non-Polymer Coated Stents
9.3. Polymer Coated Stents
9.3.1. Bioabsorbable Polymer Stents
9.3.2. Durable Polymer Stents
10. Drug Eluting Stent Market, by Material Type
10.1. Introduction
10.2. Metal Stents
10.2.1. Cobalt Chromium
10.2.2. Platinum Chromium
10.2.3. Stainless Steel
10.3. Polymer Stents
11. Drug Eluting Stent Market, by Application
11.1. Introduction
11.2. Cardiology
11.3. Peripheral Vascular Disease
11.4. Renal Artery Stenosis
12. Drug Eluting Stent Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Cardiology Clinics
12.4. Hospitals
12.4.1. Academic Hospitals
12.4.2. Private Hospitals
12.5. Research and Academic Institutes
13. Drug Eluting Stent Market, by Drug Type
13.1. Introduction
13.2. Biolimus
13.3. Everolimus
13.4. Paclitaxel
13.5. Sirolimus
13.6. Zotarolimus
14. Drug Eluting Stent Market, by Generation
14.1. Introduction
14.2. First Generation
14.3. Second Generation
14.4. Third Generation
15. Drug Eluting Stent Market, by Patient Type
15.1. Introduction
15.2. Diabetic Patients
15.3. Non-Diabetic Patients
16. Drug Eluting Stent Market, by Delivery System
16.1. Introduction
16.2. Balloon Expandable
16.3. Self-Expanding
17. Drug Eluting Stent Market, by Clinical Trial Phase
17.1. Introduction
17.2. Phase I
17.3. Phase II
17.4. Phase III
17.5. Post-Market Surveillance
17.6. Preclinical Studies
18. Americas Drug Eluting Stent Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Drug Eluting Stent Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Drug Eluting Stent Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. Abbott Laboratories
21.3.2. Alvimedica
21.3.3. Arkray, Inc.
21.3.4. B. Braun
21.3.5. Biosensors International Group, Ltd.
21.3.6. Biotronik
21.3.7. Boston Scientific Corporation
21.3.8. Cook Medical LLC
21.3.9. HEXACATH
21.3.10. KYOTO MEDICAL PLANNING Co., Ltd.
21.3.11. Lepu Medical Technology (Beijing) Co., Ltd.
21.3.12. Medtronic PLC
21.3.13. Meril Life Sciences Pvt. Ltd.
21.3.14. MicroPort Scientific Corporation
21.3.15. REVA Medical LLC
21.3.16. Shandong JW Medical Systems LTD.
21.3.17. Terumo Corporation
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. DRUG ELUTING STENT MARKET MULTI-CURRENCY
FIGURE 2. DRUG ELUTING STENT MARKET MULTI-LANGUAGE
FIGURE 3. DRUG ELUTING STENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2024 VS 2030 (%)
FIGURE 24. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2024 VS 2030 (%)
FIGURE 26. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRUG ELUTING STENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIODEGRADABLE POLYMER STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY NON-POLYMER-BASED STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY NON-POLYMER COATED STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DURABLE POLYMER STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PLATINUM CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY RENAL ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CARDIOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIOLIMUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY EVEROLIMUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PACLITAXEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY SIROLIMUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY ZOTAROLIMUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DIABETIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY NON-DIABETIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY SELF-EXPANDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POST-MARKET SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PRECLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 97. CANADA DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. CANADA DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. CANADA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 100. CANADA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 101. CANADA DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 102. CANADA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. CANADA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. CANADA DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 105. CANADA DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 106. CANADA DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 107. CANADA DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. CANADA DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 109. CANADA DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 110. MEXICO DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. MEXICO DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. MEXICO DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. MEXICO DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. MEXICO DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 119. MEXICO DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 120. MEXICO DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. MEXICO DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 122. MEXICO DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 164. CHINA DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. CHINA DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 167. CHINA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 168. CHINA DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 169. CHINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. CHINA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. CHINA DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. CHINA DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 173. CHINA DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 174. CHINA DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 175. CHINA DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 176. CHINA DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 177. INDIA DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. INDIA DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. INDIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 180. INDIA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 181. INDIA DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 182. INDIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. INDIA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. INDIA DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 185. INDIA DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 186. INDIA DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 187. INDIA DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 188. INDIA DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 189. INDIA DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 203. JAPAN DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. JAPAN DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. JAPAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 206. JAPAN DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 207. JAPAN DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 208. JAPAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. JAPAN DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. JAPAN DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. JAPAN DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 212. JAPAN DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 213. JAPAN DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 214. JAPAN DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 215. JAPAN DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 268. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 281. THAILAND DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. THAILAND DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 283. THAILAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 284. THAILAND DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 285. THAILAND DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 286. THAILAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. THAILAND DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. THAILAND DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. THAILAND DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 290. THAILAND DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 291. THAILAND DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 292. THAILAND DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 293. THAILAND DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 294. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 302. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 303. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 304. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 305. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 306. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 321. DENMARK DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 322. DENMARK DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. DENMARK DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 324. DENMARK DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 325. DENMARK DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 326. DENMARK DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. DENMARK DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. DENMARK DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 329. DENMARK DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 330. DENMARK DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 331. DENMARK DRUG ELUTING STENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 332. DENMARK DRUG ELUTING STENT MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 333. DENMARK DRUG ELUTING STENT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 334. EGYPT DRUG ELUTING STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 335. EGYPT DRUG ELUTING STENT MARKET SIZE, BY COATING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 336. EGYPT DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED STENTS, 2018-2030 (USD MILLION)
TABLE 337. EGYPT DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 338. EGYPT DRUG ELUTING STENT MARKET SIZE, BY METAL STENTS, 2018-2030 (USD MILLION)
TABLE 339. EGYPT DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 340. EGYPT DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. EGYPT DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 342. EGYPT DRUG ELUTING STENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 343. EGYPT DRUG ELUTING STENT MARKET SIZE, BY GENERATION, 2018-2030 (USD MILLION)
TABLE 344. EGY

Companies Mentioned

  • Abbott Laboratories
  • Alvimedica
  • Arkray, Inc.
  • B. Braun
  • Biosensors International Group, Ltd.
  • Biotronik
  • Boston Scientific Corporation
  • Cook Medical LLC
  • HEXACATH
  • KYOTO MEDICAL PLANNING Co., Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • REVA Medical LLC
  • Shandong JW Medical Systems LTD.
  • Terumo Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Drug Eluting Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Drug Eluting Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Drug-Eluting Stents Market Report ?2025-2033? - Product Image

Drug-Eluting Stents Market Report ?2025-2033?

  • Report
  • 122 Pages
  • Global
From
Drug Eluting Stent Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Drug Eluting Stent Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Drug-Eluting Stents - Global Strategic Business Report - Product Image

Drug-Eluting Stents - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Drug-Eluting Stent Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Drug-Eluting Stent Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Drug Eluting Stent Market

The Drug Eluting Stent (DES) market is a subset of the drug delivery market. DES are medical devices used to treat coronary artery disease. They are inserted into the artery and release a drug over time to prevent the artery from narrowing again. The DES market has grown in recent years due to the increasing prevalence of cardiovascular diseases and the need for more effective treatments. The DES market is expected to continue to grow as new technologies are developed and the demand for more effective treatments increases. Some of the major players in the DES market include Abbott, Boston Scientific, Medtronic, Biotronik, and Terumo. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.